Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
February-2019 Volume 17 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
February-2019 Volume 17 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

M3, a natural lignan xyloside, exhibits potent anticancer activity in HCT116 cells

  • Authors:
    • Weidong Shen
    • Yu Zhao
    • Haijiao Chen
    • Ting Zhang
    • Shenbao Wu
    • Pengfei Liu
  • View Affiliations / Copyright

    Affiliations: Department of Gastroenterology, The Affiliated Jiangyin Hospital of Nantong University, Jiangyin, Jiangsu 214400, P.R. China, School of Pharmacy, Nantong University, Nantong, Jiangsu 226019, P.R. China, Department of Center Laboratory, The Affiliated Jiangyin Hospital of Nantong University, Jiangyin, Jiangsu 214400, P.R. China, Department of Gastroenterology, The Affiliated Yiwu Hospital of Wenzhou Medical College, Yiwu, Zhejiang 322000, P.R. China
    Copyright: © Shen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 2117-2122
    |
    Published online on: December 12, 2018
       https://doi.org/10.3892/ol.2018.9823
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

4‑O‑(2',3',4'‑tri‑O‑methyl‑β‑D‑xylopyranosyl) diphyllin (M3) is a cytotoxic compound that was first isolated from the aerial parts of Phyllanthus taxodiifolius. The current study demonstrated that M3, a lignan xyloside, exhibits anticancer effects in a number of cancer cell lines by MTT test, including HCT116 cells. An association was identified between M3 treatment and the reduced proliferation of cancer cells; the half maximal inhibitory concentration (IC50) value of M3 ranged from 0.08 to 1.12 µM. Furthermore, M3 was revealed to exhibit a stronger antiproliferative effect by Annexin‑V‑FLUOS test compared with VP‑16, another natural lignan used in cancer treatment. Notably, the IC50 value of M3 with MTT test in HCT116 cells was 0.08 µM. In addition, it was revealed that M3 could induce apoptosis in HCT116 cells in a caspase‑3‑dependent manner at a lower concentration compared with VP‑16. Further analysis identified that the antiproliferation effect of M3 was associated with the promotion of microtubule depolymerization by CytoDYNAMIX Screen 03 Tubulin Polymerization assay. In summary, the current study demonstrated that M3 could inhibit proliferation and induce apoptosis in HCT116 cells, which supports a potential therapeutic application of M3 in cancer treatment, particularly in colon cancer.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Weymouth-Wilson AC: The role of carbohydrates in biologically active natural products. Nat Prod Rep. 14:99–110. 1997. View Article : Google Scholar : PubMed/NCBI

2 

Seeberger PH and Werz DB: Automated synthesis of oligosaccharides as a basis for drug discovery. Nat Rev Drug Discov. 4:751–763. 2005. View Article : Google Scholar : PubMed/NCBI

3 

Gui M, Shi DK, Huang M, Zhao Y, Sun QM, Zhang J, Chen Q, Feng JM, Liu CH, Li M, et al: D11, a novel glycosylated diphyllin derivative, exhibits potent anticancer activity by targeting topoisomerase IIα. Invest New Drugs. 29:800–810. 2011. View Article : Google Scholar : PubMed/NCBI

4 

Shi DK, Zhang W, Ding N, Li M and Li YX: Design, synthesis and biological evaluation of novel glycosylated diphyllin derivatives as topoisomerase II inhibitors. Eur J Med Chem. 47:424–431. 2012. View Article : Google Scholar : PubMed/NCBI

5 

Pradheepkumar CP, Panneerselvam N and Shanmugam G: Cleistanthin A causes DNA strand breaks and induces apoptosis in cultured cells. Mutat Res. 464:185–193. 2000. View Article : Google Scholar : PubMed/NCBI

6 

You Y: Podophyllotoxin derivatives: Current synthetic approaches for new anticancer agents. Curr Pharm Des. 11:1695–1717. 2005. View Article : Google Scholar : PubMed/NCBI

7 

Meenakshi J, Shanmugam G and Cleistanthin A: a diphyllin glycoside from Cleistanthus collinus, is cytotoxic to PHA-stimulted (proliferating) human lymphocytes. Drug Dev Res. 51:187–190. 2000. View Article : Google Scholar

8 

Hemmati S, Schneider B, Schmidt TJ, Federolf K, Alfermann AW and Fuss E: Justicidin B 7-hydroxylase, a cytochrome P450 monooxygenase from cell cultures of Linum perenne Himmelszelt involved in the biosynthesis of diphyllin. Phytochemistry. 68:2736–2743. 2007. View Article : Google Scholar : PubMed/NCBI

9 

Zhang ZT, Ma J, Zhu L and Zhao Y: Synthesis and identification of cytotoxic diphyllin glycosides as vacuolar H(+)-ATPase inhibitors. Euro J Med Chem. 82:466–471. 2014. View Article : Google Scholar

10 

Zhao Y, Ni C, Zhang Y and Zhu L: Synthesis and bioevaluation of diphyllin glycosides as novel anticancer agents. Arch. Pharm (Weinheim). 345:622–628. 2012. View Article : Google Scholar

11 

Tuchinda P, Kumkao A, Pohmakotr M, Sophasan S, Santisuk T and Reutrakul V: Cytotoxic arylnaphthalide lignan glycoside from the aerial parts of Phyllanthus taxodiifolius. Plant Med. 72:60–62. 2006. View Article : Google Scholar

12 

Chen C, Wang CC, Wang Z, Geng WY, Xu H, Song XM and Luo DQ: Cytotoxic activity of a synthetic deoxypodophyllotoxin derivative with an opened D-ring. J Asian Nat Prod Res. 18:486–494. 2016. View Article : Google Scholar : PubMed/NCBI

13 

Kandil S, Wymant JM, Kariuki BM, Jones AT, McGuigan C and Westwell AD: Novel cis-selective and non-epimerisable C3 hydroxy azapodophyllotoxins targeting microtubules in cancer cells. Eur J Med Chem. 3:311–325. 2016. View Article : Google Scholar

14 

López-Terrada D, Cheung SW, Finegold MJ and Knowles BB: Hep G2 is a hepatoblastoma-derived cell line. Hum Pathol. 40:1512–1515. 2009. View Article : Google Scholar

15 

Jaing JD, Davis AS, Middleton K, Ling YH, Perez-Soler R, Holland JF and Bekesi JG: 3-(Iodoacetamido)-benzoylurea: A novel cancericidal tubulin ligand that inhibits microtubule polymerization, phosphorylates bcl-2 and induces apoptosis in tumor cells. Cancer Res. 58:5389–5395. 1998.PubMed/NCBI

16 

Davis AS, Jiang JD, Middleton KM, Wang Y, Weisz I, Ling YH and Bekesi JG: Novel suicide ligands of tubulin arrest cancer cells in S-phase. Neoplasia. 1:498–507. 1999. View Article : Google Scholar : PubMed/NCBI

17 

Hyman AA, Middleton K, Centola M, Mitchison TJ and Carbon J: Microtubule-motor activity of a yeast centromere-binding protein complex. Nature. 359:533–536. 1992. View Article : Google Scholar : PubMed/NCBI

18 

Shin JW, Son JY, Kang JK, Han SH, Cho CK and Son CG: Trichosanthes kirilowii tuber extract induces G2/M phase arrest via inhibition of tubulin polymerization in HepG2 cells. J Ethnopharmacol. 115:209–216. 2008. View Article : Google Scholar : PubMed/NCBI

19 

Chen FH, Zhang LB, Qiang L, Yang Z, Wu T, Zou MJ, Tao L, You QD, Li ZY, Yang Y and Guo QL: Reactive oxygen species-mitochondria pathway involved in LYG-202-induced apoptosis in human hepatocellular carcinoma HepG(2) cells. Cancer Lett. 296:96–105. 2010. View Article : Google Scholar : PubMed/NCBI

20 

Solier S and Pommier Y: MDC1 cleavage by caspase-3: A novel mechanism for inactivating the DNA damage response during apoptosis. Cancer Res. 71:906–913. 2011. View Article : Google Scholar : PubMed/NCBI

21 

Hande KR, Hagey A, Berlin J, Cai Y, Meek K, Kobayashi H, Lockhart AC, Medina D, Sosman J, Gordon GB and Rothenberg ML: The pharmacokinetics and safety of ABT-751, a novel, orally bioavailable sulfonamide antimitotic agent: Results of a phase 1 study. Clin Cancer Res. 12:2834–2840. 2006. View Article : Google Scholar : PubMed/NCBI

22 

Kuo CC, Hsieh HP, Pan WY, Chen CP, Liou JP, Lee SJ, Chang YL, Chen LT, Chen CT and Chang JY: BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo. Cancer Res. 64:4621–4628. 2004. View Article : Google Scholar : PubMed/NCBI

23 

Benaka Prasad SB, Vinaya K, Ananda Kumar CS, Swarup S and Rangappa KS: Synthesis of novel 6-fluoro-3-(4-piperidinyl)- 1,2-benzisoxazole derivatives as antiproliferative agents: A structure-activity relationship study. Invest New Drugs. 27:534–542. 2009. View Article : Google Scholar : PubMed/NCBI

24 

Kroemer G, Dallaporta B and Resche-Rigon M: The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol. 60:619–642. 1998. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Shen W, Zhao Y, Chen H, Zhang T, Wu S and Liu P: M3, a natural lignan xyloside, exhibits potent anticancer activity in HCT116 cells. Oncol Lett 17: 2117-2122, 2019.
APA
Shen, W., Zhao, Y., Chen, H., Zhang, T., Wu, S., & Liu, P. (2019). M3, a natural lignan xyloside, exhibits potent anticancer activity in HCT116 cells. Oncology Letters, 17, 2117-2122. https://doi.org/10.3892/ol.2018.9823
MLA
Shen, W., Zhao, Y., Chen, H., Zhang, T., Wu, S., Liu, P."M3, a natural lignan xyloside, exhibits potent anticancer activity in HCT116 cells". Oncology Letters 17.2 (2019): 2117-2122.
Chicago
Shen, W., Zhao, Y., Chen, H., Zhang, T., Wu, S., Liu, P."M3, a natural lignan xyloside, exhibits potent anticancer activity in HCT116 cells". Oncology Letters 17, no. 2 (2019): 2117-2122. https://doi.org/10.3892/ol.2018.9823
Copy and paste a formatted citation
x
Spandidos Publications style
Shen W, Zhao Y, Chen H, Zhang T, Wu S and Liu P: M3, a natural lignan xyloside, exhibits potent anticancer activity in HCT116 cells. Oncol Lett 17: 2117-2122, 2019.
APA
Shen, W., Zhao, Y., Chen, H., Zhang, T., Wu, S., & Liu, P. (2019). M3, a natural lignan xyloside, exhibits potent anticancer activity in HCT116 cells. Oncology Letters, 17, 2117-2122. https://doi.org/10.3892/ol.2018.9823
MLA
Shen, W., Zhao, Y., Chen, H., Zhang, T., Wu, S., Liu, P."M3, a natural lignan xyloside, exhibits potent anticancer activity in HCT116 cells". Oncology Letters 17.2 (2019): 2117-2122.
Chicago
Shen, W., Zhao, Y., Chen, H., Zhang, T., Wu, S., Liu, P."M3, a natural lignan xyloside, exhibits potent anticancer activity in HCT116 cells". Oncology Letters 17, no. 2 (2019): 2117-2122. https://doi.org/10.3892/ol.2018.9823
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team